In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 44 for your search:
Drug:  enzastaurin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9817, H6Q-MC-JCBF, NCT00295815

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9823, H6Q-MC-JCBJ, PRELUDE, NCT00332202

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9815, H6Q-MC-S008, NCT00402116

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11183, H6Q-MC-S030, NCT00452413

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-03-C-0018, NCT00052663

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8360, H6Q-MC-JCAO, NCT00088205

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8670, H6Q-MC-JCAQ, NCT00105092

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9098, H6Q-MC-JCAR, NCT00192114

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10463, H6Q-US-S002, NCT00267020

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10651, H6Q-US-S004, NCT00308750

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10287, H6Q-MC-S001, NCT00309140

12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10517, H6Q-MC-S015, NCT00386087

13.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000517318, GOG-0170J, LILLY-H6Q-MC-S025, NCT00407758

14.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10708, H6Q-MC-S019, NCT00391118

15.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10723, H6Q-MC-S009, MCC-14787, MCC-104545, LILLY-H6Q-MC-S009A, U01-CA-101222, NCT00387816, NCT00414960

16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10710, H6Q-MC-S020, NCT00415363

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10737, H6Q-MC-S024, NCT00428714

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9819, H6Q-MC-S013, NCT00436280

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10538, H6Q-MC-S018, NCT00437268

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9824, H6Q-MC-S028, NCT00451178

21.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10736, H6Q-MC-S023, NCT00451555

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11311, H6Q-MC-S032, NCT00466440

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 8671, H6Q-MC-S011, NCT00475644

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 4849, H6Q-MC-JCAI, UCLA-0210010, LILLY-H6Q-MC-JCA, CWRU-080213J, LILY-1402, UNMC-18502, NCT00042666

25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11491, H6Q-MC-S039, NCT00509821
1   
New Search